Saw Palmetto · Serenoa repens

锯叶棕 · Saw Palmetto

Place · Level 3

BPH 头号草药补剂 · 早期小试阳性 · STEP NEJM 2006 + CAMUS JAMA 2011 大型 RCT 全部翻车 · Cochrane 2012 meta 无效 · AUA 不推荐 · 自然 BPH 治疗营销的教科书反例

Connected to · 2

contrast · 2

BPH
Saw palmetto is the best-selling prostate supplement, yet the STEP and CAMUS trials were both negative and the AUA 2023 guideline does not recommend it for LUTS/BPH — safe but ineffective.
Milk Thistle
Two specimens of one pattern: early small trials uniformly positive, then large randomized trials nulled it — Cochrane pooling and SyNCH for milk thistle, STEP and CAMUS for saw palmetto.

Saw palmetto + BPH context

Stop 1/5

锯叶棕 + BPH 故事

Saw palmetto = Serenoa repens berry:

Latin name Serenoa repens (Arecaceae, palm family)Native to the southeastern US — Florida / South Carolina / Georgia swamps and sandy soilThe plant itself is a short shrub-form palm with serrated leaves → 'saw' leafMedicinal part: ripe berry (deep purple-black, oily, rich in fatty acids + plant sterols)Native Americans (Seminole / Creek and others) used it traditionally — for male reproduction + diuresis + vigorTransplanted to Europe in the late 19th century — used for 'prostate / bladder symptoms'
The problem it targets: BPH (benign prostatic hyperplasia):

Epidemiology:~50% of 50-year-old men, ~80% of 80-year-old men have histological BPHAbout half experience lower urinary tract symptoms (LUTS):Frequency / nocturia / hesitancy / weak stream / sense of incomplete emptying / urgencyMechanism:Aging + sustained testosterone (T) exposure → hyperplasia of prostatic stroma + epitheliumDHT (dihydrotestosterone) is the real driver — T converted by 5α-reductaseVolume + contractile tone increase → urethral compression → storage + voiding symptoms
Saw palmetto's 'mechanism hypothesis':

5α-reductase inhibition (effective in vitro; whether the in vivo dose is sufficient is questionable)Anti-inflammatory + anti-edema (fatty acid + sterol components)α-receptor modulation (speculative, weak evidence)Low androgen receptor affinity (animal data)
The problem is: 'the mechanism sounds reasonable' isn't the same as 'clinically effective' — this is one of the most common misalignments in nutritional medicine, and saw palmetto is the textbook counterexample.

Why marketing has succeeded for so long:

Europe: Germany + France once positioned standardized saw palmetto extracts (Permixon® / SabalSelect® etc.) as first-line for BPHUnited States: after DSHEA 1994, saw palmetto became one of the best-selling male supplementsThe appeal of 'natural + no doctor visit + no side effects' to middle-aged menPre-2000 small RCTs mostly positive → marketing foundationPost-2006 large RCTs failed → but market inertia + marketing continued

Read story Open mechanism

Educational content, not medical advice — consult a clinician.

Back